Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

被引：46

作者：

Carotti, Andrea ^{[1
]}

Marinozzi, Maura ^{[1
]}

Custodi, Chiara ^{[1
]}

Cerra, Bruno ^{[1
]}

Pellicciari, Roberto ^{[1
,2
]}

Gioiello, Antimo ^{[1
]}

Macchiarulo, Antonio ^{[1
]}

机构：

[1] Univ Perugia, Dipartimento Sci Farmaceut, I-06123 Perugia, Italy

[2] TES Pharma Srl, I-06073 Corciano, Perugia, Italy

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 19期

关键词：

Bile acid homeostasis; Farnesoid X receptor; Natural ligands; Nuclear receptors; Synthetic ligands; SPONGE THEONELLA-SWINHOEI; CHOLESTEROL-RAISING FACTOR; ORPHAN NUCLEAR RECEPTOR; SALT EXPORT PUMP; MARINE SPONGE; BIOLOGICAL EVALUATION; ACTIVATED RECEPTOR; SULFATED POLYHYDROXYSTEROIDS; SCHISANDRA-GLAUCESCENS; CELL-PROLIFERATION;

D O I：

10.2174/1568026614666141112094058

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The modulation of FXR receptor remains an attractive area in drug discovery to develop novel therapeutic opportunities for liver and metabolic disorders. Despite the large variety of FXR ligands reported so far, only a very restricted number of agonists have entered in clinical settings. In this review article we provide the reader with an overview on the different classes of natural and synthetic ligands that have been developed by academic groups and pharmaceutical companies to target FXR. We discuss their structure-activity relationships, analyzing the binding modes that some of these compounds adopt to interact with the receptor.

引用

页码：2129 / 2142

页数：14

共 50 条

[21] Farnesoid X receptor (FXR): Structures and ligands (vol 19, pg 2148, 2021)
Jiang, Longying
Zhang, Huajun
Xiao, Desheng
Wei, Hudie
Chen, Yongheng
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 1227 - 1228
[22] Farnesoid X receptor (FXR) is a bile acid receptor that mediates transcriptional regulation of the cholesterol 7α-hydroxylase gene (CYP7A1) by bile acids
Chiang, JY
Kimmel, R
Weinberger, C
Stroup, D
HEPATOLOGY, 1999, 30 (04) : 319A - 319A
[23] Nutraceutical targeting of the bile acid receptor, farnesoid X receptor, for intestinal disease
Fallon, Ciara M.
Quach, Andrew
Lajczak-McGinley, Natalia
Smyth, Jessica S.
Curley, Caitriona E.
Hazel, Karl
Boland, Karen
O'Toole, Aoibhlinn
Barrett, Kim E.
Sheridan, Helen
Keely, Stephen J.
FASEB JOURNAL, 2022, 36
[24] Neutraceutical Targeting of the Bile Acid Receptor, Farnesoid X Receptor, for Intestinal Disease
Fallon, Ciara
Edupuganti, Omprakash
Lajczak-McGinley, Natalia
Sheridan, Helen
Keely, Stephen
FASEB JOURNAL, 2020, 34
[25] A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
Evans, Mark J.
Mahaney, Paige E.
Borges-Marcucci, Lisa
Lai, KehDih
Wang, Shuguang
Krueger, Julie A.
Gardell, Stephen J.
Huard, Christine
Martinez, Robert
Vlasuk, George P.
Harnish, Douglas C.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (03): : G543 - G552
[26] Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
She, Jianglian
Gu, Tanwei
Pang, Xiaoyan
Liu, Yonghong
Tang, Lan
Zhou, Xuefeng
FRONTIERS IN PHARMACOLOGY, 2022, 12
[27] Modulation of beta cell function and glucose homeostasis by the bile acid farnesoid X receptor (FXR)
Schittenhelm, B.
Duefer, M.
Kaehny, V.
Wagner, R.
Hoerth, K.
Krippeit-Drews, P.
Drews, G.
DIABETOLOGIA, 2013, 56 : S47 - S47
[28] Role of farnesoid X receptor and bile acids in alcoholic liver disease
Sharon Manley
Wenxing Ding
ActaPharmaceuticaSinicaB, 2015, 5 (02) : 158 - 167
[29] Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis
Mohammed, Thamer Abdulla
Zalzala, Munaf H.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
[30] Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
Takahashi, Shogo
Tanaka, Naoki
Fukami, Tatsuki
Xie, Cen
Yagai, Tomoki
Kim, Donghwan
Velenosi, Thomas J.
Yan, Tingting
Krausz, Kristopher W.
Levi, Moshe
Gonzalez, Frank J.
HEPATOLOGY COMMUNICATIONS, 2018, 2 (12) : 1567 - 1582

← 1 2 3 4 5 →